Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective Studies

OBJECTIVES:To provide health-care providers, patients, and physicians with an exhaustive assessment of prospective studies on rates of complications and fatalities associated with endoscopic retrograde cholangiopancreatography (ERCP).METHODS:We searched MEDLINE (1977–2006) for prospective surveys on adult patients undergoing ERCP. “Grey literature” was sought by looking at cited references to identify further relevant studies. Data on postprocedural pancreatitis, bleeding, infections, perforations, and miscellaneous events as well as their associated fatalities were extracted independently by two reviewers. Sensitivity analysis was performed to test for data consistency between multicenter versus single center studies, and old (1977–1996) versus recent (1997–2005) reports.RESULTS:In 21 selected surveys, involving 16,855 patients, ERCP-attributable complications totaled 1,154 (6.85%, CI 6.46–7.24%), with 55 fatalities (0.33%, CI 0.24–0.42%). Mild-to-moderate events occurred in 872 patients (5.17%, CI 4.83–5.51%), and severe events in 282 (1.67%, CI 1.47–1.87%). Pancreatitis occurred in 585 subjects (3.47%, CI 3.19–3.75%), infections in 242 (1.44%, CI 1.26–1.62%), bleeding in 226 (1.34%, CI 1.16–1.52%), and perforations in 101 (0.60%, CI 0.48–0.72%). Cardiovascular and/or analgesia-related complications amounted to 173 (1.33%, CI 1.13–1.53%), with 9 fatalities (0.07%, CI 0.02–0.12%). As compared with old reports, morbidity rates increased significantly in most recent studies: 6.27% versus 7.51% (Pc = 0.029).CONCLUSIONS:ERCP remains the endoscopic procedure that carries a high risk for morbidity and mortality. Complications continue to occur at a relatively consistent rate. The majority of events are of mild-to-moderate severity.

[1]  Michelle A. Anderson,et al.  Complications of ERCP. , 2003, Gastrointestinal endoscopy.

[2]  A. R. Tanner.  ERCP: present practice in a single region. Suggested standards for monitoring performance , 1996, European journal of gastroenterology & hepatology.

[3]  C. Fischbacher,et al.  Impact of laparoscopic cholecystectomy: a population-based study , 2000, The Lancet.

[4]  C Liguory,et al.  Endoscopic sphincterotomy complications and their management: an attempt at consensus. , 1991, Gastrointestinal endoscopy.

[5]  J. Neoptolemos,et al.  Successes, failures, early complications and their management following endoscopic sphincterotomy: Results in 394 consecutive patients from a single centre , 1985, The British journal of surgery.

[6]  C. Crosta,et al.  Complications of diagnostic and therapeutic ERCP: a prospective multicenter study , 2001, American Journal of Gastroenterology.

[7]  P. Cotton.  Analysis of 59 ERCP lawsuits; mainly about indications. , 2006, Gastrointestinal endoscopy.

[8]  P. Fina,et al.  Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. , 1998, Gastrointestinal endoscopy.

[9]  P. Edwards,et al.  Prospective randomized double‐blind placebo‐controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography‐induced pancreatitis , 2001, The British journal of surgery.

[10]  S. Sherman,et al.  ERCP and biliary endoscopic sphincterotomy-induced pancreatitis. , 1998, Gastrointestinal endoscopy clinics of North America.

[11]  R. Trap,et al.  Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. , 1999, Endoscopy.

[12]  E. G. Hahn,et al.  Analysis of the Risk Factors Associated with Endoscopic Sphincterotomy Techniques: Preliminary Results of a Prospective Study, with Emphasis on the Reduced Risk of Acute Pancreatitis with Low-Dose Anticoagulation Treatment , 2000, Endoscopy.

[13]  NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. , 2002, NIH consensus and state-of-the-science statements.

[14]  J. van Dam,et al.  Risk factors for complications after performance of ERCP. , 2002, Gastrointestinal endoscopy.

[15]  R. Dickinson,et al.  Post‐ERCP pancreatitis and hyperamylasaemia: the role of operative and patient factors , 1998, European journal of gastroenterology & hepatology.

[16]  K. Tsalis,et al.  Post-ERCP Pancreatitis and Hyperamylasemia: Patient-Related and Operative Risk Factors , 2002, Endoscopy.

[17]  T. Eisenbach,et al.  Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists. , 2001, Gastrointestinal endoscopy.

[18]  K. Ho,et al.  Complications of endoscopic retrograde cholangiography in the post-MRCP era: a tertiary center experience. , 2005, World journal of gastroenterology.

[19]  A. Lavy,et al.  Outcome and early complications of ERCP: a prospective single center study. , 2005, Hepato-gastroenterology.

[20]  X Viviand,et al.  Complications of Endoscopic Sphincterotomy: Results From a Single Tertiary Referral Center , 2002, Endoscopy.

[21]  Svend Schulze,et al.  Complications of ERCP: a prospective study. , 2004, Gastrointestinal endoscopy.

[22]  S. Köklü,et al.  Endoscopic retrograde cholangiopancreatography in the elderly: a prospective and comparative study. , 2005, Age and ageing.

[23]  M. Freeman,et al.  Prevention of post-ERCP pancreatitis: a comprehensive review. , 2004, Gastrointestinal endoscopy.

[24]  M. Freeman.  Toward improving outcomes of ERCP. , 1998, Gastrointestinal endoscopy.

[25]  S. Sherman,et al.  ERCP‐ and Endoscopic Sphincterotomy‐Induced Pancreatitis , 1991, Pancreas.

[26]  Y. K. Chen,et al.  Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. , 1994, The American journal of gastroenterology.

[27]  T. Wilson,et al.  What are the risks of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography? , 2000, The Australian and New Zealand journal of surgery.

[28]  Pankaj Singh,et al.  Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. , 2004, Gastrointestinal endoscopy.

[29]  A. Andriulli,et al.  Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. , 2003, JOP : Journal of the pancreas.

[30]  M. Lane,et al.  Complications of endoscopic retrograde cholangiopancreatography. , 2003, The New Zealand medical journal.

[31]  T. Zágoni,et al.  Complications of endoscopic biliary sphincterotomy. , 1997, The New England journal of medicine.

[32]  R. Rutledge,et al.  A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy , 2002, American Journal of Gastroenterology.

[33]  S. Sherman,et al.  Success of ERCP at a referral center after a previously unsuccessful attempt. , 2000, Gastrointestinal endoscopy.

[34]  R. Hawes,et al.  Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. , 1991, Gastroenterology.

[35]  M. D. de Ridder,et al.  Endoscopic Papillotomy for Common Bile Duct Stones: Factors Influencing the Complication Rate , 1994, Endoscopy.

[36]  F. Prat,et al.  Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. , 2002, Gastrointestinal endoscopy.

[37]  C. Rollhauser.  Interleukin 10 and incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. , 2001, Gastroenterology.

[38]  J. Kountouras,et al.  High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial. , 2005, Gastrointestinal endoscopy.